Medical Marijuana Inc. Posts Falling Revenue, Focuses on Overseas Hemp Ventures

Gross margin for the company increased to 82%.

Medical Marijuana Inc. (OTC: MJNA) saw revenue fall in the third quarter despite cutting costs in during the period, according to financial results for the quarter ended Sept. 30. Those measures mostly benefitted margins for the company.

MJNA’s stock was trading down nearly 5% on Tuesday after the results were released.

The Oregon-based hemp operator generated $4.9 million in net revenue during the quarter, versus $9.2 million in the same period last year. Net loss for the third quarter was $2.2 million, versus $4.7 million in the same period last year. Still, the loss is an improvement from the previous quarter, when the company posted a net loss of $11 million.

MJNA posted gross profit of $4 million, versus $6.7 last year. Gross margins for the period were 82%, up versus 78% last year.

The company ended the quarter with $1.4 million in the coffers, versus $5.6 million last year. It has total liabilities of $11.8 million.

“During the third quarter MJNA continued to aggressively pursue our strategic initiatives,” said CEO Blake Schroeder.

He said the company has been working to expand its range of import permits in various international markets, announcing partnerships in Europe and in Argentina, where it has partnered with a research hospital for one of its pharmaceutical venture.

MJNA also said it had submitted a pharmaceutical product dossier in Brazil for its CBD subsidiary, HempMeds Brasil.

“I remain extremely bullish on the opportunities before us, both at home and abroad. We continue to see legislators discussing making long-needed changes to our regulatory environment that, should they pass, drastically decrease the obstacles we face in operations and expansion,” Schroeder said. “We will continue to target expansion of our brands as we work to build the world’s first truly global cannabis company.”

Adam Jackson

Adam Jackson covers the cannabis industry for The Green Market Report. He previously covered the Missouri statehouse for The Columbia Missourian and has written for The Missouri Independent. He most recently covered retail, restaurants, and other consumer companies for Bloomberg Business News. You can find him on Twitter @adam_sjackson and email him at adam.jackson@crain.com.


FundCanna

Leave a Reply

Your email address will not be published. Required fields are marked *

Choose Your News

Subscribe to the Green Market Report newsletter that gives you original content delivered straight to your inbox.

 Subscribe

By continuing I agree to your Privacy Policy and consent to receive relevant newsletters and other email communications on events, editorial features, and special partner offers from Green Market Report. I can unsubscribe or change my email preferences at any time.


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 5 hours

Inflation Shifts Cannabis Purchase Preferences, but Usage Holds Steady

@GreenMarketRpt – 5 hours

Judge Declines to Stop L.A. Social Equity Lottery

Back to Top

Choose Your News

Subscribe to the Green Market Report newsletter that gives you original content delivered straight to your inbox.

 Subscribe

By continuing I agree to your Privacy Policy and consent to receive relevant newsletters and other email communications on events, editorial features, and special partner offers from Green Market Report. I can unsubscribe or change my email preferences at any time.